# Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/infliximab-in-moderately-severe-glucocorticoid-resistant-ulcerative-colitis-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C Probert,S D Hearing,S Schreiber,T Kühbacher,S Ghosh,I D R Arnott,A Forbes |
| Citations | 362 |
| DOI | 10.1136/gut.52.7.998 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://gut.bmj.com/content/gutjnl/52/7/998.full.pdf |
| OpenAlex ID | https://openalex.org/W2112768046 |
| PMID | 12801957 |
| Type | article |
| Year | 2003 |

## Paper authors

- [C Probert](https://scholariq.org/researchers/c-probert/)

## Paper journal

- [Gut](https://scholariq.org/journals/gut/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.